Insider Buying Stocks
OFIX is part of our Insider Buying Stocks list, indicating stock insiders are buying the stock.
ORTHOFIX MEDICAL INC (OFIX) Stock Price & Overview
NASDAQ:OFIX • US68752M1080
Current stock price
12.65 USD
-0.06 (-0.47%)
At close:
12.65 USD
0 (0%)
After Hours:
The current stock price of OFIX is 12.65 USD. Today OFIX is down by -0.47%. In the past month the price increased by 8.58%. In the past year, price decreased by -10.85%.
OFIX Key Statistics
52-Week Range10.24 - 16.99
Current OFIX stock price positioned within its 52-week range.
1-Month Range11.13 - 12.99
Current OFIX stock price positioned within its 1-month range.
- Market Cap
- 507.771M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.16
- Dividend Yield
- N/A
OFIX Stock Performance
Today
-0.47%
1 Week
N/A
1 Month
+8.58%
3 Months
-5.10%
Longer-term
6 Months -20.79%
1 Year -10.85%
2 Years -2.69%
3 Years -32.82%
5 Years -71.48%
10 Years -71.09%
OFIX Stock Chart
OFIX Stock Screens
OFIX currently appears in the following ChartMill screener lists.
OFIX Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to OFIX. When comparing the yearly performance of all stocks, OFIX is a bad performer in the overall market: 79.69% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
OFIX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OFIX. Both the profitability and financial health of OFIX have multiple concerns.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
OFIX Earnings
On February 24, 2026 OFIX reported an EPS of -0.06 and a revenue of 219.91M. The company beat EPS expectations (81.02% surprise) and missed revenue expectations (-1.42% surprise).
Next Earnings DateMay 5, 2026
Last Earnings DateFeb 24, 2026
PeriodQ4 / 2025
EPS Reported-$0.06
Revenue Reported219.911M
EPS Surprise 81.02%
Revenue Surprise -1.42%
OFIX Forecast & Estimates
11 analysts have analysed OFIX and the average price target is 17.6 USD. This implies a price increase of 39.09% is expected in the next year compared to the current price of 12.65.
For the next year, analysts expect an EPS growth of -38.05% and a revenue growth 5.06% for OFIX
Analysts
Analysts81.82
Price Target17.6 (39.13%)
EPS Next Y-38.05%
Revenue Next Year5.06%
OFIX Groups
Sector & Classification
OFIX Financial Highlights
Over the last trailing twelve months OFIX reported a non-GAAP Earnings per Share(EPS) of -1.16. The EPS decreased by -11700% compared to the year before.
Income Statements
Revenue(TTM)822.31M
Net Income(TTM)-92.19M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.84% | ||
| ROE | -20.49% | ||
| Debt/Equity | 0.39 |
Chartmill High Growth Momentum
EPS Q2Q%-400%
Sales Q2Q%1.97%
EPS 1Y (TTM)-11700%
Revenue 1Y (TTM)2.85%
OFIX Ownership
Ownership
Inst Owners89.9%
Shares40.14M
Float39.00M
Ins Owners1.85%
Short Float %3.07%
Short Ratio4.24
OFIX Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 15.28 | 166.816B | ||
| ISRG | INTUITIVE SURGICAL INC | 45.56 | 165.367B | ||
| SYK | STRYKER CORP | 22.37 | 129.577B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.49 | 90.642B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.03 | 46.953B | ||
| IDXX | IDEXX LABORATORIES INC | 39.37 | 46.307B | ||
| BDX | BECTON DICKINSON AND CO | 11.62 | 45.171B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.35 | 33.834B | ||
| RMD | RESMED INC | 18.42 | 32.944B | ||
| DXCM | DEXCOM INC | 25.41 | 24.87B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.26 | 18.482B | ||
| PODD | INSULET CORP | 30.98 | 13.912B | ||
| GMED | GLOBUS MEDICAL INC - A | 21.23 | 13.095B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About OFIX
Company Profile
Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,605 full-time employees. The firm offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
Company Info
IPO: 1992-04-24
ORTHOFIX MEDICAL INC
3451 Plano Pkwy
Lewisville TEXAS 75056 US
CEO: Jon Serbousek
Employees: 1605
Phone: 12149372000
ORTHOFIX MEDICAL INC / OFIX FAQ
Can you describe the business of ORTHOFIX MEDICAL INC?
Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,605 full-time employees. The firm offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
What is the current price of OFIX stock?
The current stock price of OFIX is 12.65 USD. The price decreased by -0.47% in the last trading session.
Does OFIX stock pay dividends?
OFIX does not pay a dividend.
What is the ChartMill rating of ORTHOFIX MEDICAL INC stock?
OFIX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the Price/Earnings (PE) ratio of ORTHOFIX MEDICAL INC (OFIX)?
ORTHOFIX MEDICAL INC (OFIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.16).
How many employees does ORTHOFIX MEDICAL INC have?
ORTHOFIX MEDICAL INC (OFIX) currently has 1605 employees.